porcin
parvoviru
ppv
caus
reproduct
failur
pig
lead
econom
loss
industri
report
previous
licl
effici
impair
replic
varieti
virus
includ
coronaviru
infecti
bronchiti
viru
ibv
transmiss
gastroenter
viru
tgev
pseudorabi
herpesviru
demonstr
first
time
inhibit
ppv
replic
swine
testi
st
cell
licl
dosedepend
antivir
effect
licl
occur
earli
phase
ppv
replic
result
indic
licl
might
effect
antippv
drug
control
ppv
diseas
studi
requir
explor
mechan
antivir
effect
licl
ppv
infect
vivo
porcin
parvoviru
ppv
member
famili
parvovirida
subfamili
parvovirina
genu
protoparvoviru
parvovirus
small
nonenvelop
singlestrand
dna
virus
ppv
major
caus
reproduct
failur
sow
signific
cofactor
porcin
postwean
multisystem
wast
syndrom
ppv
first
isol
pig
fever
commonli
found
diseas
pig
caus
signific
econom
loss
swine
industri
today
current
vaccin
primari
measur
prevent
ppv
howev
cost
vaccin
high
might
lead
biolog
safeti
issu
recombin
mutat
virus
addit
even
vaccin
ppv
widespread
swine
although
vaccin
prevent
clinic
symptom
ppv
diseas
elimin
impair
caus
ppv
diseas
therefor
altern
strategi
drug
therapi
control
ppv
receiv
increas
attent
base
earli
research
tharid
licl
use
drug
treatment
bipolar
disord
depress
alzheim
diseas
fractur
heal
observ
rodent
treat
licl
recent
licl
show
antivir
effect
cell
infect
infecti
bronchiti
viru
ibv
avian
coronaviru
transmiss
gastroenter
viru
tgev
pseudorabi
herpesviru
indic
licl
potenti
antivir
drug
howev
known
whether
licl
inhibitori
effect
ppv
studi
antivir
activ
licl
ppv
investig
vitro
found
significantli
inhibit
ppv
replic
viru
cell
drug
ppv
isol
pig
farm
guangdong
provinc
china
march
ppv
low
virul
name
isol
pool
tissu
includ
lung
liver
kidney
dead
foetus
sow
experienc
reproduct
loss
mummif
stillborn
weak
foetus
sow
came
commerci
pig
farm
locat
guangdong
provinc
southern
china
st
cell
obtain
american
type
cultur
collect
atcc
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
usa
contain
fetal
bovin
serum
fb
co
licl
purchas
sigmaaldrich
sigma
st
loui
mo
usa
prepar
dmem
concentr
steril
passag
filter
cytotox
assay
st
cell
cultur
plate
cell
per
well
grown
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
co
cytotox
assay
perform
accord
instruct
manufactur
cell
count
donjindo
japan
briefli
st
cell
cultur
plate
wash
three
time
pb
incub
licl
seri
concentr
mm
serumfre
emem
six
wellsdilut
h
mocktreat
st
cell
serv
control
wash
pb
st
cell
incub
medium
per
well
solut
per
well
h
optic
densiti
od
measur
wavelength
nm
use
micropl
reader
biorad
usa
rel
cell
viabil
rate
determin
concentr
od
drug
od
control
licl
concentr
cytostat
concentr
cc
defin
nontox
concentr
assay
examin
effect
drug
addit
differ
stage
cours
infect
evalu
whether
licl
affect
attach
ppv
st
cell
st
cell
plate
infect
ppv
moi
treat
nontox
concentr
mm
licl
h
temperatur
allow
virus
bind
surfac
cell
enter
remov
unbound
virus
wash
pb
st
cell
lysat
prepar
three
cycl
freez
thaw
viral
load
calcul
determin
whether
licl
affect
entri
ppv
st
cell
st
cell
plate
infect
ppv
moi
h
remov
unbound
viru
wash
pb
st
cell
treat
nontox
concentr
mm
licl
h
subsequ
drug
remov
st
cell
grown
fresh
medium
h
st
cell
lysat
prepar
three
cycl
freez
thaw
viral
load
calcul
determin
whether
licl
affect
replic
ppv
st
cell
st
cell
plate
infect
ppv
moi
h
allow
viru
entri
remov
unbound
viru
wash
pb
st
cell
treat
nontox
concentr
mm
licl
h
subsequ
st
cell
lysat
prepar
three
cycl
freez
thaw
viral
load
calcul
evalu
time
infect
viral
replic
impact
drug
st
cell
plate
infect
ppv
moi
h
st
cell
wash
three
time
pb
grown
fresh
medium
set
h
licl
ad
cell
nontox
concentr
mm
hour
postinfect
includ
drugsensit
phase
viru
replic
st
cell
lysat
prepar
three
cycl
freez
thaw
viral
load
calcul
h
postinfect
st
cell
seed
plate
h
infect
cell
lysat
experi
serial
dilut
tenfold
dmem
ad
st
cell
five
well
incub
h
tissu
cultur
infecti
dose
tcid
calcul
method
reed
muench
confirm
inhibitori
effect
licl
ppv
replic
st
cell
lysat
viral
replic
stage
assay
subject
realtim
pcr
total
dna
extract
trizol
reagent
invitrogen
carlsbad
ca
usa
accord
instruct
manufactur
cdna
made
use
thermo
scientif
revert
aid
first
strand
cdna
synthesi
kit
thermo
scientif
usa
realtim
quantit
pcr
target
gene
ppv
carri
primer
shown
tabl
use
real
time
pcr
system
appli
biosystem
usa
sybr
select
master
mix
kit
appli
biosystem
usa
accord
instruct
manufactur
rel
mrna
express
level
calcul
ddct
method
use
gadph
intern
control
normal
mean
mrna
level
mocktreat
group
set
ifa
perform
confirm
inhibitori
effect
licl
ppv
replic
wash
pb
st
cell
ppv
replic
stage
assay
treat
nontox
concentr
licl
allow
viru
entri
fix
paraformaldehyd
pb
min
permeabil
triton
pb
min
wash
st
cell
incub
rabbit
antippv
antibodi
h
subsequ
rhodamineconjug
goat
antirabbit
igg
zhongshan
china
use
secondari
antibodi
wash
three
time
pb
nuclear
stain
dapi
perform
refer
protein
express
accord
instruct
manufactur
invitrogen
carlsbad
ca
usa
wash
fluoresc
observ
leica
b
confoc
microscop
leica
wetzlar
germani
experi
perform
triplic
data
present
mean
standard
deviat
sd
student
ttest
perform
compar
set
data
differ
twotail
pvalu
less
consid
signific
cytotox
assay
perform
accord
ti
instruct
manufactur
rel
cell
viabil
treatment
licl
concentr
mm
wherea
viabil
treatment
licl
concentr
mm
fig
necessari
verifi
concentr
licl
nontox
cell
ensur
result
experi
unaffect
drug
licl
concentr
cytostat
concentr
cc
concentr
inhibit
prolifer
exponenti
grow
cell
defin
nontox
concentr
concentr
mm
licl
cc
valu
differ
cell
morpholog
compar
mocktreat
cell
observ
data
shown
concentr
therefor
chosen
maximum
concentr
licl
antivir
assay
assay
perform
evalu
effect
licl
ppv
attach
entri
cell
viral
attach
assay
ppv
titer
st
cell
treat
mm
licl
mocktreat
st
cell
approxim
fig
fact
signific
differ
viral
titer
drugtreat
mocktreat
st
cell
observ
viral
attach
assay
indic
licl
effect
attach
ppv
st
cell
similarli
viral
entri
assay
ppv
titer
cell
treat
mm
licl
mocktreat
st
cell
also
approxim
fig
fact
signific
differ
viral
titer
drugtreat
mocktreat
st
cell
observ
viral
entri
assay
indic
licl
effect
ppv
entri
st
cell
virus
attach
cell
receptor
enter
cell
temperatur
rais
fig
thu
inhibitori
effect
licl
ppv
replic
occur
primarili
earli
stage
previou
studi
demonstr
licl
antivir
effect
herp
simplex
viru
use
concentr
rang
mm
furthermor
licl
differ
concentr
show
antivir
effect
infect
cell
infecti
bronchiti
viru
ibv
avian
coronaviru
transmiss
gastroenter
viru
tgev
howev
inhibit
observ
influenza
virus
viru
caus
encephalomyocard
studi
antivir
effect
licl
occur
earli
phase
ppv
replic
treatment
licl
concentr
mm
show
signific
toxic
st
cell
concentr
differ
cell
morpholog
found
licltreat
st
cell
mocktreat
st
cell
data
shown
investig
phase
ppv
replic
sensit
licl
treatment
st
cell
expos
licl
sever
point
viral
life
cycl
licl
effect
ppv
attach
entri
st
cell
demonstr
directli
affect
attach
viru
cell
receptor
passag
virus
cell
inhibitori
effect
licl
ppv
replic
occur
primarili
earli
stage
infect
ppv
h
allow
viru
entri
st
cell
treat
seri
nontox
concentr
licl
viral
load
st
cell
lysat
cultiv
h
measur
evalu
replic
ppv
st
cell
realtim
pcr
ifa
result
clearli
demonstr
inhibit
ppv
replic
licl
dosedepend
li
et
al
report
ppv
infect
inhibit
attach
stage
even
stage
diammonium
glycyrrhizin
therefor
differ
drug
inhibit
viru
differ
mechan
conclus
inhibit
ppv
replic
st
cell
licl
occur
dosedepend
manner
earli
phase
viral
replic
result
indic
licl
potenti
effect
antippv
drug
studi
requir
explor
mechan
antivir
effect
licl
ppv
infect
vivo
st
cell
infect
ppv
moi
follow
treatment
mm
licl
indic
time
hpi
viru
titer
determin
hpi
indic
cell
treat
licl
valu
repres
mean
standard
deviat
three
independ
experi
asterisk
indic
signific
differ
mocktreat
drugtreat
cell
p
p
